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  29 
ABSTRACT 30 
Compression garments are frequently used to facilitate recovery from strenuous exercise.  31 
Purpose: To identify the effects of two different grades of compression garment on recovery 32 
indices following strenuous exercise.  Methods: Forty five recreationally active participants 33 
(n=26 males and n=19 females) completed an eccentric exercise protocol consisting of 100 34 
drop jumps. Following the exercise protocol participants were matched for body mass and 35 
randomly but equally assigned to either a high (HI) compression pressure group, a low 36 
(LOW) compression pressure group, or a sham ultrasound group (SHAM).  Participants in 37 
the high (HI) and low (LOW) compression groups wore the garments for 72 h post-exercise; 38 
participants in the SHAM group received a single treatment of 10 minutes sham ultrasound.  39 
Measures of perceived muscle soreness, maximal voluntary contraction (MVC), counter 40 
movement jump height (CMJ), creatine kinase (CK), C-reactive protein (CRP) and 41 
myoglobin (Mb) were assessed before the exercise protocol and again at 1, 24, 48 and 72 h 42 
post exercise. Data were analysed using a repeated measures ANOVA.  Results: Recovery of 43 
MVC and CMJ was significantly improved with the HI compression garment (p < 0.05).  A 44 
significant time by treatment interaction was also observed for jump height at 24 h post 45 
exercise (p < 0.05).  No significant differences were observed for parameters of soreness and 46 
plasma CK, CRP and Mb.  Conclusions: The findings of this study indicate that the pressures 47 
exerted by a compression garment affect recovery following exercise-induced muscle damage 48 
(EIMD), with a higher pressure improving recovery of muscle function.  49 
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  60 
INTRODUCTION 61 
Exercise that is unaccustomed or unfamiliar in nature can lead to the experience of exercise-62 
induced muscle damage (EIMD) (1,2).  Symptoms associated with EIMD include decreased 63 
force production, decreased range of motion (ROM) and the experience of muscle soreness, 64 
all of which can negatively affect performance (3).  Consequently, there is a growing interest 65 
in strategies that can minimise the experience of EIMD and accelerate recovery. 66 
 67 
Compression garments are often used to aid recovery following strenuous exercise.  The use 68 
of compression originates from clinical settings where limb compression is used to treat a 69 
range of inflammatory conditions including lymphedema (4), deep vein thrombosis (5) and 70 
chronic venous insufficiency (6).  Research investigating the use of compression as a 71 
recovery modality in an athletic setting remains equivocal, with some research indicating 72 
favourable effects (7-10) and other research reporting no benefits (11-12).  Whilst the exact 73 
mechanism for the benefit of compression garments remains unclear it is thought that 74 
application of compression can positively affect haemodynamics and attenuates swelling by 75 
facilitating lymphatic drainage and reducing the increase in osmotic pressure experienced as a 76 
result of tissue damage (13).  In addition, compression is thought to provide mechanical 77 
support to the injured limb which may in turn prevent force decrements (13). 78 
 79 
One methodological disparity between studies is the level of compression exerted by the 80 
garment.  It is likely that the effects of a compression garment depend on the amount of 81 
compression applied (14), however if the degree of compression exerted by the garment is 82 
insufficient or too high, a beneficial effect is unlikely (15-16). Low levels of compression 83 
may be insufficient to modulate blood flow or osmotic pressure, and levels of compression 84 
that are too high may have a restrictive effect on blood flow.  Optimal levels of compression 85 
beneficial to performance and recovery have yet to be determined, with current 86 
recommendations based upon clinical guidelines (17).  However, pressures that are effective 87 
in a clinical population may not be effective in an athletic population.   88 
 89 
Improved venous return has been observed at pressures of 20-25 mmHg at the calf and thigh 90 
respectively, with the authors of this study proposing pressures of 15.2-17.3 mmHg as the 91 
minimum required in order to achieve elevations in venous return (18). However it should be 92 
noted that these minimum pressures are estimations, calculated by assessing the cardiac 93 
output response to three different levels of compression garments (10-8, 15-12 and 20-16 94 
mmHg at the calf and thigh respectively). Sperlich et al. (19) investigated the effects of knee-95 
high socks that applied compression pressures of 0, 10, 20, 20 and 40 mmHg and observed no 96 
effect at any pressure on cardio-respiratory and metabolic parameters during submaximal 97 
running. In contrast to this, another study indicated that compression garments exerting 98 
pressures of 20 and 40 mmHg may improve alpine skiing performance by enabling a deeper 99 
tuck position with attenuated perceived exertion; however the authors indicated that the 100 
garment exerting 40 mmHg may reduce blood flow (20). 101 
 102 
A variety of compression pressures have been used in current research ranging from 10-12 103 
mmHg (21) up to 40 mmHg (19).  A major limitation with current research investigating the 104 
efficacy of compression is that a large number of studies have failed to measure exact 105 
interface pressures applied by the garments (4, 22-25).  Previous research has highlighted 106 
large variations in the degree of pressure exerted by compression garments across a 107 
population, with a number of individuals receiving low levels of compression (26).  This 108 
variation is likely due to differences in limb size and tissue structure within a particular size 109 
category of garment (22). Thus it is possible the degree of compression exerted was 110 
insufficient to enhance recovery in several studies that have observed no benefit (2).  111 
Knowledge of the pressures applied by compression garments is fundamental to developing 112 
understanding on how a garment affects parameters of performance and recovery.  Without 113 
knowledge on the precise pressures applied in research studies we cannot accurately interpret 114 
or compare findings (15).   Therefore the aim of this investigation was to assess whether 115 
garments exerting a higher degree of pressure are more effective in facilitating recovery 116 
compared to garments exerting a lower pressure.    117 
 118 
 119 
METHODOLOGY 120 
Participants 121 
Forty five recreationally active participants from any sport or training background (n=26 122 
male, n=19 female) volunteered to participate in this study.  Following ethical approval all 123 
participants completed a health screening questionnaire and gave written informed consent.  124 
Individuals with a history of musculoskeletal injury and inflammatory disorders were 125 
excluded from participating in this study.  All participants were asked to arrive at the 126 
laboratory in a rested state  and refrain from heavy exercise in the 48 h preceding the study 127 
and for 72 h following the muscle damaging protocol; in addition, participants were required 128 
to refrain from using any recovery strategy for the duration of the investigation.  Participant 129 
characteristics are presented in table 1. 130 
 131 
Experimental overview  132 
Participants were matched for weight and randomly, but equally assigned, to either a low 133 
(LOW, n=15), or high (HI, n=15) compression treatment group, or a sham-ultrasound group 134 
(SHAM, n=15).  Participants reported to the laboratory for familiarisation and baseline 135 
testing 1 h prior to the muscle damaging protocol.  During the familiarisation participants 136 
were given a full verbal explanation of how each variable was to be measured and were 137 
required to undertake practice attempts of the muscle function tests until performance in each 138 
of the tests reached a plateau.  Following the familiarisation participants sat with their feet up 139 
for 20minutes before the collection of baseline data commenced. Base line data was collected 140 
for the dependent variables creatine kinase (CK), high sensitivity C-reactive protein (CRP), 141 
myoglobin (Mb), global lower limb muscle soreness and quadriceps soreness, counter 142 
movement jump (CMJ), and maximum voluntary contraction (MVC) of the knee extensors.  143 
These variables were analysed again 1, 24, 48 and 72 h post muscle damaging protocol.  144 
Participants were required to attend the laboratory for post testing at the same time of day and 145 
variables were always collected in the same order.  146 
 147 
Muscle damage procedure  148 
The muscle damaging protocol consisted of 100 drop jumps from a 0.6 m platform.  149 
Participants performed 5 sets of 20 drop jumps, with 10 seconds between each jump and a 2 150 
minute rest period between sets. Participants were instructed to jump maximally upon landing 151 
each jump.   152 
 153 
Treatment groups  154 
Participants in the LOW compression group were fitted with a full length, lower limb, 155 
commercially available compression garment (MA1551b men’s compression tights, 2XU, or 156 
WA1552b women’s compression tights, 2XU, Melbourne, Australia) fitted according to 157 
manufacturer’s guidelines based upon participants’ height and weight.   Pressure exerted by 158 
the compression garment was measured using a pressure-measuring device (Kikuhime, TT 159 
Medi Trade, Søleddet, Denmark), validated for use in this setting (6).  Pressure was measured 160 
at the front thigh at the mid-point between the superior aspect of the patella and the inguinal 161 
crease and at the medial aspect of the calf at the site of maximal girth.   Measurements were 162 
taken at each site whilst the subject was standing in the anatomical position.   Measurements 163 
were repeated three times with the mean value recorded.  Average pressures exerted by the 164 
garments were reported as 8.1 ± 1.3 mmHg at the thigh and 14.8 ± 2.1 mmHg at the calf.   165 
 166 
Participants in the HI compression group wore a full length lower limb clinical medical grade 167 
II compression garment (Alleviant clinical class II medical stockings, Jobskin, Nottingham, 168 
UK) fitted according to manufacturer’s guidelines based upon leg circumference measured at 169 
7 locations on the leg.  These garments exerted an average pressure of 14.8 ± 2.2 mmHg at 170 
the thigh and 24.3 ± 3.7 mmHg at the calf.  All garments were worn for 72 h post exercise, 171 
participants were only allowed to remove them to shower.  Participants were each given two 172 
pairs of the same garments to allow rotation when washing.    173 
 174 
Participants in SHAM received 10 min of sham ultrasound comprised of 5 minutes each thigh 175 
(Combined therapy ultrasound/inferential, Shrewsbury Medical, Shropshire, UK).  A water 176 
soluble ultrasound gel (Aquasonic 100 ultrasound transmission gel, Parker Laboratries, 177 
Fairfield, USA) was applied to the thigh, using the ultrasound head the gel was spread across 178 
the skin using circular movements. Throughout the duration of the ultrasound treatment the 179 
unit was turned off and obscured from view of the participants.  All treatments were applied 180 
immediately following the muscle damaging protocol. 181 
 182 
Dependent variables 183 
Muscle soreness: Global lower limb muscle soreness and localised soreness in the 184 
quadriceps muscle group was analysed using a 200 mm visual analogue scale (VAS) with ‘no 185 
pain’ at 0 mm and ‘unbearable pain’ at 200 mm.  Participants stood with their feet shoulder 186 
width apart with hands on hips and were asked to perform a squat to 90°, return to standing 187 
and mark their subjective feelings of pain on the scale. 188 
 189 
Muscle function: Maximal voluntary contraction was assessed using a strain gauge (MIE 190 
Medical Research Ltd., Leeds, UK).  Participants were seated on a platform in a standardised 191 
position, with their hip and knee joints flexed at 90°. The strain gauge was attached 2 cm 192 
above the malleoli of the left ankle and participants were required to maximally extend the 193 
knee against the device for 3 s, verbal encouragement was given for the duration. Participants 194 
performed three repetitions, each separated by 1 min, with the greatest value recorded as 195 
MVC.   Measurements were recorded in newtons.  196 
 197 
Counter movement jump height was assessed using a force plate (Kistler 9287BA force 198 
platform, Kistler Instruments Ltd, Hamshire, UK).  Participants were instructed to stand with 199 
their hands on their hips and perform a maximal jump on command.  Participants performed 200 
three jumps the best of which was taken for analysis.  Data from 5 participants (n=2 LOW, 201 
n=1 HI and N=2 SHAM) were not included in the jump data analysis due to technical issues 202 
with the equipment. 203 
 204 
Blood measures: CK, high sensitivity CRP, and Mb were analysed from plasma blood 205 
samples.  Approximately 8.5 mL of blood was collected from the antecubital vein into 206 
lithium heparin vacutainers.  Following collection, the sample was immediately placed in a 207 
refrigerated centrifuge and spun at 3500 rpm, a relative centrifugal force of 3000 g, for 20 208 
minutes at 4°C to enable the separation of plasma.  The plasma was immediately frozen at -209 
80°C for later analysis.  Plasma CK and CRP Mb were measured using an automated 210 
analyser (Advia 2400, Chemistry System, Siemens Health Care Diagnostics, USA).  211 
Manufacturer’s report an intra-sample CV for the analyser of <3% at high and low 212 
concentrations and expected baseline sample ranges of 32-294 IU.L-1 and < 3 pg.mL-1 for CK 213 
and CRP, respectively. Plasma Mb was analysed using an electrochemiluminescence immuno 214 
assay (ECLIA) (Elecsys 2010, Roche Diagnostics GmbH, Germany). Manufacturer’s report 215 
an intra-sample CV for the analyser of <4% and expected values of 25-72ng.ml-1. 216 
 217 
Statistical Analysis  218 
All data analyses was carried out using SPSS for Windows version 21, and values are 219 
reported as mean ± SD. Independent samples t-tests were used  to identify any differences in 220 
group characteristics at baseline.  All dependent variables were assessed using a treatment by 221 
time repeated measures analysis of variance (ANOVA).  Where a significant effect was 222 
observed, interaction effects were further examined using a Bonferroni post hoc analysis.  A 223 
significance level of p ≤ 0.05 was applied throughout.  Effect sizes, using Cohen’s d, and 224 
90% confidence intervals (CI) were calculated to assess magnitude of effect on the change 225 
from baseline at 1, 24, 48 and 72 h post exercise. Threshold values were set at 0.2, small; 0.5, 226 
moderate; and 0.8, large. 227 
  228 
 229 
RESULTS 230 
Effect sizes and 90% CI comparing change from baseline with 1, 24, 48 and 72 h post 231 
exercise can be seen for each variable in table 2. A significant time effect was observed for 232 
global lower limb muscle soreness (F
2.639,1
=31.509, p < 0.001) and soreness of the quadriceps 233 
(F
2.988,1
=45.865, p < 0.001) indicating that there was a change in muscle soreness over time.  234 
Further post hoc Bonferroni tests indicated significant differences from baseline occurred at 235 
all time points in both global and quadriceps soreness (p < 0.05).   No significant group (F
2, 42
 236 
=1.081, p = 0.325) or interaction effects (F
5.278,2=
0.861, p = 0.515) were observed for global 237 
lower limb soreness.  This was consistent with the group (F
2,42
=0.972, p = 0.387) and 238 
interaction effects observed for quadriceps soreness (F
5.976, 2  
=0.855, p = 0.530) (Figures 1a 239 
and 1b).   240 
 241 
Significant time effects were observed for MVC (F
3.084, 1
=49.760, p < 0.001), Bonferroni post 242 
hoc tests indicated that a significant difference from baseline occurred at all time points (p < 243 
0.05).  Values reduced to 81.6 ± 9.0, 84.3 ± 6.3 and 81.4 ± 9.2 % of baseline 1 h after the 244 
damaging protocol and returning to 90.6 ± 11.6, 99.9 ± 9.9 and 91.2 ± 9.7% of baseline at 72 245 
h post in the LOW, HI and SHAM groups respectively.  A significant treatment effect was 246 
observed for MVC (F2,42  = 3.832, p = 0.030), however there was no significant time by 247 
treatment interaction (F6.169,2 = 1.824, p = 0.097).  Further post hoc analysis indicated the 248 
significant difference occurred between the HI and SHAM groups (p = 0.036) (figure 2).   249 
 250 
Significant time effects were observed for Jump height (F4,1 = 11.202, p < 0.001), further post 251 
hoc analysis indicated that significant differences from baseline occurred at all time points (p 252 
< 0.05) figure 3.  A significant time by treatment effect (F8,2 = 2.99, p  = 0.004) and a 253 
significant treatment effect (F2,37 = 3.741, p = 0.33) was observed for jump height. Further, 254 
post hoc analysis indicated the significant treatment effect occurred between the HI and LOW 255 
compression groups (p = 0.032) and the time by treatment interaction occurred at 24 h post 256 
exercise between the HI and LOW compression groups (p = 0.002) (figure 3). 257 
  258 
Whilst an overall significant time effect was observed for CK (F2.353,1 = 2.980, p = 0.021), 259 
further post hoc analysis failed to indicate a significant effect at any time point  (p > 0.05).  260 
Post exercise plasma CK values were elevated 1 h post exercise in all experimental groups 261 
and remained raised for the duration of the study.   No significant group (F2,42 = 0.174, p = 262 
0.841) or interaction effects were observed for CK (F4.706,2 = 1.383, p = 0.240), data is 263 
presented in table 3.   264 
 265 
There was no significant time effect (F4,1  = 0.615, p = 0.570), group effect (F2,11 = 0.511, p = 266 
0.558) or time by group effect (F8,2 = 0.217, p = 0.858) for CRP. This was also consistent 267 
with Mb where there was also no significant time (F4,1  = 1.915, p = 0.110), group (F2,11 = 268 
0.387, p = 0.681) or time by group effect (F8,2 = 1.016, p = 0.462) (table 3). 269 
 270 
 271 
DISCUSSION  272 
The aim of this study was to investigate the effects of different compression pressures on 273 
indices of recovery following EIMD in a recreationally active population.  The main finding 274 
was that a garment exerting higher levels of compression is more effective in modulating 275 
muscle function following exercise that induces muscle damage when compared to a garment 276 
exerting lower levels of compression and a sham treatment group.   277 
 278 
In this study muscle function decreased following the damaging protocol, this was evidenced 279 
by a significant time effect for both MVC and jump height (p<0.05).  Recovery of strength 280 
was greatest in the HI compression group with participants recovering to 99.9 ± 9.9% of 281 
baseline MVC values at 72 h post exercise compared to 90.6 ± 11.6 and 91.2 ± 9.7% in the 282 
LOW and SHAM group. A significant difference between treatment groups was observed for 283 
MVC with the difference occurring between the HI compression group and the SHAM group  284 
This observation is supported by the large effect sizes observed between the HI and SHAM 285 
group between 24 – 72 h post exercise and the moderate to large effect sizes observed 286 
between the LOW and HI group at the same time points. These observations suggest that 287 
strength recovered at an accelerated rate over 72 h in the HI compression group.   288 
 289 
Additionally Jump height was significantly higher 24 h post exercise in the HI group 290 
compared to the LOW group, indicating that compression garments exerting higher levels of 291 
compression may be beneficial in improving recovery of muscle function.  The failure to 292 
observe a significant treatment effect between the HI and SHAM group was unexpected, 293 
however a large effect size was seen at 24h post exercise.  Although this study attempted to 294 
control for a placebo effect by using sham ultrasound, it is possible that the observation of 295 
improved recovery in the HI group may be linked to the participant’s belief that tighter 296 
compression garments have a positive response on recovery; this is a limitation of the study.  297 
 298 
Improved recovery of muscle function has been observed in previous research (9,13,27), and 299 
has been attributed to an enhanced repair of the contractile elements of the muscle (13).  300 
Furthermore the application of compression may provide mechanical support to the limb 301 
resulting in reduced movement of the tissues and offering ‘dynamic immobilisation’, whilst 302 
still enabling use of the limb, this has been proposed to increase motor unit activation during 303 
tissue injury (13, 28).  However, the exact mechanism responsible for this is unclear.  Several 304 
studies have failed to observe improved muscle function with the use of a compression 305 
garment (11,21-22).  However as the exact level of compression exerted by the garments was 306 
not measured in these studies it is possible the garments used did not exert enough pressure to 307 
be of benefit. 308 
 309 
No significant between group differences were observed for global lower limb soreness and 310 
soreness in the quadriceps, this is similar to previous findings (11-12,21). However, moderate 311 
effect sizes were observed at 48 h post exercise between the HI and SHAM group for global 312 
muscle soreness and at 24 h post exercise between the LOW and HI group for quadriceps 313 
muscle soreness, indicating soreness was lower in the HI group.   314 
 315 
The experience of DOMS arises as a result of damage to the soft tissue leading to an 316 
inflammatory response which causes localised oedema in the affected limb.  The presence of 317 
oedema can stimulate pain afferents bringing about the experience of soreness (28).  The 318 
application of compression may reduce the level of oedema by attenuating the magnitude of 319 
the inflammatory response thus reducing the severity of the soreness experienced (21,27).  320 
Whilst a large body of research has observed reductions in perceived muscle soreness with 321 
the use of compression garments (13,24,27), these studies failed to control for placebo effect, 322 
this needs to be considered when interpreting findings.   323 
 324 
Creatine kinase and Mb are released from the muscle during the experience of muscle 325 
damage and as such are frequently used as markers of EIMD (21-22).  Given the absence of a 326 
significant time effect for Mb and a non-significant post hoc results for the time effect in CK 327 
it is likely that the muscle damage protocol in this study did not cause sufficient enough 328 
muscle damage for a large CK and Mb response.  Previous investigations have observed 329 
reductions in concentrations of CK with the application of compression (2,22).  It is worth 330 
noting the peak concentrations of CK observed within the control group of this study (586 331 
IU.L-1), is much smaller than the values observed in other studies (2194 IU.L-1(7) and ~1750 332 
IU.L-1 (13)) all of whom found beneficial effects of compression. It is possible compression is 333 
not effective at modulating clearance of CK at lower concentrations.   334 
 335 
A number of investigations have observed reduced inflammation with the use of a 336 
compression garment (9,13,21), however this study failed to observe any significant group 337 
differences for the inflammatory marker CRP.  Furthermore no significant time effect was 338 
observed for this marker, it is possible that muscle damage was not severe enough to cause a 339 
large inflammatory response. Regardless of the magnitude of the inflammatory response it 340 
appears the exercise protocol was severe enough to cause pronounced performance 341 
decrements and elevations in muscle soreness.   342 
 343 
 344 
PRACTICAL APPLICATION 345 
Whether compression garments exert sufficient pressure to be effective has been raised by a 346 
number of investigators (21-22). This study provides evidence for the importance of 347 
compression pressure in modulating parameters of recovery.  The majority of previous 348 
research has failed to measure exact pressures exerted by compression garments, until the 349 
reporting of interface pressure occurs in research on compression it is difficult to identify 350 
optimal levels of compression necessary for improving recovery.  More knowledge is needed 351 
on the effects of different compression pressures in order to assist practitioners in the 352 
selection of a garment for a particular role.  353 
 354 
 355 
CONCLUSIONS 356 
In conclusion, a compression garment exerting higher compression pressures (14.8 ± 2.2 and 357 
24.3 ± 3.7 mmHg at the thigh and calf respectively) is more effective at improving muscle 358 
function than a compression garment exerting lower pressures (8.1 ± 1.3 mmHg at the thigh 359 
and 14.8 ± 2.1 mmHg at the calf) and a SHAM treatment group. Furthermore, no treatment 360 
group was superior in aiding the removal of plasma markers of muscle damage or 361 
inflammation.  The degree of pressure exerted by the garment is an important factor in 362 
determining the efficacy of compression garments in recovery.  These findings highlight the 363 
importance of wearing a correctly fitting garment when using compression as a recovery 364 
modality.  365 
 366 
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 440 
FIGURE LEGENDS 441 
Figure 1. Perceived ratings of global lower limb soreness (A) and quadriceps soreness (B) 442 
for the LOW, HI and SHAM treatment groups.  Values are presented as mean ± SD. No 443 
significant differences were observed between treatment groups.  ⱡ denotes significant time 444 
effect compared to baseline.   445 
 446 
Figure 2. Percentage change in MVC for the LOW, HI and SHAM treatment groups.  The HI 447 
compression group was significantly different from the SHAM treatment group.  Values are 448 
presented as mean ± SD, data was recorded in newtons and converted to a percentage change. 449 
* denotes a significant difference from the HI group. ⱡ denotes significant time effect 450 
compared to baseline.   451 
 452 
Figure 3. Percentage change in CMJ for the LOW, HI and SHAM treatment groups.  The HI 453 
compression group was significantly different from the LOW compression group at 24 h post 454 
exercise.  Values are presented as mean ± SD. * denotes a significant difference from HI 455 
group. ⱡ denotes significant time effect compared to baseline.  α denotes significant 456 
interaction between HI and LOW compression groups.  457 
 458 
Table 1. Participant characteristics for the low compression pressure group (LOW), high 459 
compression pressure group (HI) and sham ultrasound treatment group (SHAM).  Values are 460 
presented as mean ± SD. 461 
 462 
Table 2. Effect sizes ± 90% CI of the application of treatment on markers of exercise-induced 463 
muscle damage.   464 
 465 
Table 3. Plasma markers of CK, MB and CRP for the LOW, HI and SHAM treatment 466 
groups.  No significant differences were observed between treatment groups.  Values are 467 
presented as mean ± SD.  * denotes significant time effect was observed.  468 
